GlaxoSmithKline (GSK) is to standardise on an information processing platform from Autonomy to enable it to begin automating more of its information processing operations.
The pharmaceutical giant is globally implementing Autonomy’s IDOL 7 platform.
“It was essential for us to select an infrastructure that could integrate all of our data regardless of format and maintain performance,” said Ingo Elfering, vice-president of GSK global application services.
“The decision to deploy Autonomy to underpin and automate a wide spectrum of information processing operations globally enables the company to minimise the costs and risks of transacting real-time digital information while simultaneously maximising its value,” said Elfering.
Mike Lynch, CEO of Autonomy, said, “I am delighted that GSK has selected Autonomy after a competitive procurement, bringing the benefits of Idol 7 to hundreds of thousands of users around the globe.
Comment on this article: firstname.lastname@example.org